Atlas Trials

Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple Myeloma

Clinical trial NCT00398515 · COMPLETED

Trial details

NCT number
NCT00398515
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Refractory Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Start date
2007-03-01
Primary completion
2012-02-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.